LastShadow's Position Trading Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : LastShadow's Position Trading

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Susan Saline who wrote (20833)	8/27/1999 12:11:00 PM
From: U Up U Down	Read Replies (2) of 43080

Susan, I did nothing with DAB. Still watching it. Here is a hoot, a $105 target on a $3 stock. HIV (used to be CELI?) has a bad history, is this just another chapter? Absolutely no info on Gateway Capital Partners found on Web. ( BW)(GATEWAY-CAPTIAL-PARTNERS) Gateway Capital Partners Announces Investment Opinion on Cel-Sci Corporation Business Editors NOTE TO EDITORS: The following is an investment opinion issued by Gateway Capital Partners LONDON--(BUSINESS WIRE)--Aug. 27, 1999-- Gateway Capital Begins Coverage of Cel-Sci Corporation (HIV) With a STRONG BUY Recommendation and a Price Target of $105 Per Share businesswire.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next